Literature DB >> 2205528

Autoantibodies to the insulin receptor are infrequent findings in type 1 (insulin-dependent) diabetes mellitus of recent onset.

N Rochet1, J L Sadoul, B Ferrua, J Kubar, J F Tanti, P Bougnères, B Vialettes, E Van Obberghen, Y Le Marchand-Brustel, P Freychet.   

Abstract

To determine whether autoantibodies to the insulin receptor may represent markers of Type 1 (insulin-dependent) diabetes, the prevalence of such antibodies was investigated in sera of 60 newly diagnosed untreated Type 1 diabetic patients. A sensitive assay, based on enzyme linked immunosorbent assay has been set up which detects antibodies to the insulin receptor irrespective of their potentially inhibiting effect on insulin binding. Moreover, this method allows easy determination of the immunoglobulin class involved in the anti-receptor activity. Among the 60 sera examined, only one was found to contain anti-insulin receptor autoantibodies (IgG class). In view of our data, we conclude that autoantibodies to the insulin receptor are infrequent findings in Type 1 diabetes of recent onset.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205528     DOI: 10.1007/bf00404090

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

Review 1.  Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders.

Authors:  M Salvi; H Fukazawa; N Bernard; Y Hiromatsu; J How; J R Wall
Journal:  Endocr Rev       Date:  1988-11       Impact factor: 19.871

2.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.

Authors:  D A McClain; H Maegawa; J Lee; T J Dull; A Ulrich; J M Olefsky
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

3.  Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child.

Authors:  N Rochet; S Blanche; J C Carel; A Fischer; F L Deist; C Griscelli; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

4.  Tissue-specific antibodies against the fibroblast insulin receptor in a patient with lupus nephritis and hypoglycemia.

Authors:  R De Pirro; P Borboni; R Lauro; A Festa; I Testa; C De Martinis; B A Maddux; I D Goldfine
Journal:  Diabetes       Date:  1985-11       Impact factor: 9.461

5.  Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. I. Characterization of the antibodies.

Authors:  Y Shechter; D Elias; R Maron; I R Cohen
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

6.  Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. II. Effects on glucose homeostasis and the insulin receptor.

Authors:  D Elias; R Maron; I R Cohen; Y Schechter
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

7.  Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease.

Authors:  E G Walters; J M Tavaré; R M Denton; G Walters
Journal:  Lancet       Date:  1987-01-31       Impact factor: 79.321

8.  Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.

Authors:  S Srikanta; A T Ricker; D K McCulloch; J S Soeldner; G S Eisenbarth; J P Palmer
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

9.  Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes.

Authors:  R Maron; D Elias; B M de Jongh; G J Bruining; J J van Rood; Y Shechter; I R Cohen
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

10.  Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes.

Authors:  E Van Obberghen; M Ksauga; A Le Cam; J A Hedo; A Itin; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  1 in total

Review 1.  Islet cell autoantigens in insulin-dependent diabetes.

Authors:  M A Atkinson; N K Maclaren
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.